Vetter wins two coveted awards
Leading CDMO is granted both the WorldStar Award for Vetter-Ject and a 2016 CMO Leadership Award.
The World Packaging Organization (WPO) has awarded Vetter the WorldStar Award 2016 for its syringe closure system Vetter-Ject. The WorldStar competition is one of the major events of the WPO, and its award represents the pre-eminent international award in packaging. Vetter has now won four internationally recognized awards for a product only released in July 2015. Two of the awards, won prior to the products launch, include the IF Design Award, and the Red Dot Design Award. Recently, Vetter-Ject won the “German Packaging Award 2015”. At the same time, Vetter is proud to have also been awarded a CMO Leadership Award 2016 in four categories.
The WorldStar competition is open to any pack or packaging material that has won a recognized or domestic international award related to packaging in either 2014 or 2015. Winning of the German Packaging Award 2015 assured Vetter’s submission to the WorldStar competition. Representatives from 19 packaging associations judged 293 projects entered into the competition from 35 countries. The judging session took place over 2 days in October, 2015 as part of the 95th WPO Board Meeting activities. Vetter had previously won the WorldStar award in 1998 for the Vetter Lyo-Ject dual chamber syringe.
“The winning of this award, certainly one of the most prestigious in the field of global packaging, is very gratifying to Vetter, and yet another affirmation of the value that Vetter-Ject brings to the biopharmaceutical industry,” said Dr Claus Feussner, Senior Vice President, Vetter Development Service. “The three awards we had already received, combined with the WorldStar Award, are a validation of the novel design and technological advances of Vetter-Ject.” Since its introduction in July, Vetter has had positive feedback both from the market and our customers about this system.
Vetter-Ject offers more options for filling highly sensitive compoundsPharmaceutical and biotech companies are increasingly developing drugs that incorporate sensitive and complex compounds. Administering these drugs requires an injection system that can be used flexibly while being safe and simple to handle. Vetter-Ject is such a system, consisting of a needle hub and a needle shield. Due to the baked-in siliconization process for the glass barrel, less silicon oil than commonly used is necessary, making Vetter-Ject particularly suitable for silicone-sensitive drug products. The silicon content of the syringe can also be adjusted according to the requirements of the customer. Thus, the amount of silicon used; as well as the related particle load, can be reduced by up to 80% when compared to the standard siliconization process applied to conventional syringe systems.
Vetter-Ject is ready-to-use with an integrated needle that is simple to handle and user-friendly. The tamper-evident closure enables that any attempt at opening of the closure system will be immediately and permanently visible to the naked eye. Vetter-Ject®can be used with a wide range of primary packaging options like different stoppers and glass barrels, which can be customized according to the needs of the drug product.
Vetter is a winner of a 2016 CMO Leadership Award in four categoriesThe efficient vetting of potential CMO partners is a difficult experience for pharmaceutical and biopharmaceutical executives. To assist in this process, Life Science Leader magazine created the CMO Leadership Awards. More than 80 contract manufactures were assessed by 26 performance metrics in Industry Standard Research’s (ISR) annual Contract Manufacturing Quality Benchmarking survey. For 2016, Vetter was named the winner in four categories including, quality, capabilities, expertise, and compatibility.
“Vetter is pleased to be a recipient of this award, particularly since it is a direct reflection of our customers’ experience in having worked right alongside us,” said Peter Soelkner, Managing Director. “Their nomination and the granting of the award is a clear indication to Vetter that we continue to exceed the expectations of our peers in areas of critical importance to their business.
Unlike other industry awards that are based on a subjective voting or nomination process, only votes from companies that have cooperated on an outsourced project within the past 18 months in using CMO services are counted.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance